Agena Bioscience and CapitalBio Technology to Develop Cost-Effective Genetic Testing for Commercial Agricultural Applications

SAN DIEGO, Calif., March 1, 2016 – Agena Bioscience (Agena) today announced its partnership to co-develop commercial tests with CapitalBio Technology (CapitalBio) for a variety of agricultural applications on the MassARRAY® System. The tests will be made available as certified services through CapitalBio. “CapitalBio has established a strong presence... Read More

Agena Bioscience Announces the Expansion of its Headquarters in San Diego, California, to Better Serve its Growing Customer Base

SAN DIEGO, Calif., January 11, 2016 — Agena Bioscience today announced the expansion of its headquarters to a new site in San Diego. Located at 4755 Eastgate Mall, the new 55,000-square-foot facility houses the company’s laboratory, manufacturing, and office workforce. “We’re tremendously excited about moving our headquarters into a... Read More

Agena Bioscience and Diatech Pharmacogenetics Announce Plan to Launch Actionable, Targeted CE-IVD Marked Oncology Assays for Colon, Lung, and Melanoma Treatment

SAN DIEGO, Calif., Oct. 27, 2015 — Agena Bioscience announced today the planned commercial launch of its CE-IVD marked MassARRAY® Dx PLUS assays for gene-specific mutation testing to aid in the selection of targeted therapy regimens. Agena Bioscience will introduce the first diagnostic kits in partnership with Diatech Pharmacogenetics.... Read More
Showing: 11–20 of 31